Medical

Agentic AI in Blood Cancers: From First Clues to Personalized Treatment - and Back to Life

Artificial Intelligence

Agentic AI in Blood Cancers: From First Clues to Personalized Treatment - and Back to Life

The moment a routine blood test blinks red, life tilts, within hours, you might hear about smear reviews, flow cytometry, bone marrow biopsies, and genomic sequencing followed by decisions about chemotherapy, targeted pills, or Chimeric Antigen Receptor T-cell therapy (CAR-T) and then the long vigil against relapse. In that whirlwind,

By Thamsanqa Sibiya Founder & CEO - Siza
Rheumatoid Arthritis: Understanding, Managing, and Living With It

Medicine

Rheumatoid Arthritis: Understanding, Managing, and Living With It

This article was originally published in the Asian Hospital & Healthcare Management Magazine. Rheumatoid arthritis (RA) is a chronic, systematic autoimmune disease causing joint inflammation and potential organ damage. Early diagnosis and treatment are crucial to slowing progression. Advances in DMARDs, biologics, and targeted therapies have transformed RA management, enabling

By Thamsanqa Sibiya Founder & CEO - Siza
Persistent Fatigue and Weakness in Myelodysplastic Syndromes (MDS): Understanding and Managing a debilitating Symptom

cancer

Persistent Fatigue and Weakness in Myelodysplastic Syndromes (MDS): Understanding and Managing a debilitating Symptom

Persistent fatigue and weakness are among the most common and life-altering symptoms experienced by individuals living with Myelodysplastic Syndromes (MDS). While MDS is primarily a group of bone marrow disorders, its effects go far beyond the cellular level, significantly impacting quality of life, daily functioning, and emotional well-being. This article

By Thamsanqa Sibiya Founder & CEO - Siza